Canada Life’s ONCOLYTICS BIOTECH INC ONCY Stock Holding History

Canada Life’s Portfolio ONCY Stock Details ONCY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-52,158	Closed	-$67K	–	2539
2014 Q2	$67K	Hold	52,158	–	–	﹤0.01%	1809
2014 Q1	$93K	Sell	52,158 -181,000	-78%	-$306K	﹤0.01%	1471
2013 Q4	$359K	Sell	233,158 -14,051	-6%	-$31.7K	﹤0.01%	935
2013 Q3	$597K	Hold	247,209	–	–	﹤0.01%	830
2013 Q2	$711K	Buy	+247,209	New	+$684K	﹤0.01%	504

Other funds holding ONCY

1832 Asset Management Toronto, Ontario, Canada $199B AUM 37.98% 1-Year Est. Return

RFC

Russell Frank Company Seattle, Washington $56.9B AUM 2.13% 1-Year Est. Return

Bank of Nova Scotia Toronto, Ontario, Canada $66.2B AUM 46.3% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return

VFS

VSR Financial Services Overland Park, Kansas $607M AUM 0.85% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return

VKH

Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

Canada Life's ONCY Position: Q3 2014 in Review

Canada Life sold out of ONCOLYTICS BIOTECH INC (ONCY) in Q3 2014, closing a stake of 52,158 shares — an estimated $67K sold.

Canada Life first reported a position in ONCY in Q2 2013 and held it in 5 quarters. The position peaked at $711K in Q2 2013. 30 funds tracked by Wall St. Rank hold ONCY as of Q3 2014.

Canada Life reported no remaining ONCOLYTICS BIOTECH INC position as of Q3 2014 after selling out during the quarter.
Canada Life sold 52,158 ONCOLYTICS BIOTECH INC shares in Q3 2014, an estimated $67K.
Canada Life first reported a position in ONCOLYTICS BIOTECH INC in Q2 2013 and held it in 5 quarters.
Canada Life's ONCOLYTICS BIOTECH INC position peaked at $711K in Q2 2013.
30 funds tracked by Wall St. Rank held ONCOLYTICS BIOTECH INC as of Q3 2014.

Based on Canada Life's 13F filing for Q3 2014, filed 6 Nov 2014.